The latest coronavirus developments and scientific research on prevention and treatment.
The COVID-19 pandemic exacerbated fear of childbirth among pregnant people in the U.S., according to a new Dartmouth study. The researchers were particularly interested in understanding, from a… read more.
Sleep apnea may significantly increase the risk for long COVID in adults, according to a study led by the National Institutes of Health’s RECOVER Initiative and supported by NYU Langone… read more.
During World Immunization Week, the International Pharmaceutical Federation (FIP) offers a new resource to help countries self-assess readiness of their regulations to enable pharmacist-delivered vaccination services and, where… read more.
The time has come and gone for universal masking in healthcare settings, according to healthcare epidemiologists and infectious diseases experts from healthcare systems throughout Boston and beyond. In… read more.
A new international study finds that women vaccinated for COVID-19 have a slightly higher risk for a heavier period after vaccination. The study, led by Oregon Health &… read more.
COVID-19 Impacted Smoking Assessment Rates in Community Health Centers, Necessitating a Closer Examination on How Procedures Can be Adapted Researchers from Oregon Health & Science University and OCHIN, … read more.
Women who gave birth during the COVID-19 pandemic filled significantly more prescriptions for opioid medications, according to new research from the University of Georgia. Published in the Journal… read more.
Covid-19 vaccination does not cause concerning changes to periods, research has found. Women who have been infected with the Covid-19 virus are, however, at increased risk of menstrual… read more.
New research from Boston Medical Center found that sexually transmitted infection (STI) and HIV testing declined at the onset of the COVID-19 pandemic, while there was an increase… read more.
Researchers have developed a molecule that is, when administered nasally, extremely effective in preventing the disease caused by all known variants of the SARS-CoV-2 virus. The molecule can… read more.
A new study of some 3.6 million surgeries from National Health Service (NHS) databases in England suggests that, in most cases, it will be safe to carry out… read more.
A Kaiser Permanente study confirms the benefit of nirmatrelvir-ritonavir, also known as Paxlovid, as an early-stage treatment to prevent hospitalization for people with mild to moderate COVID-19, regardless… read more.
Advertisment
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.
